Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists. - Wikidata - wikimedia - TriplyDB

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

http://www.wikidata.org/entity/Q37428887

about

Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials Antiestrogen use reduces risk of cervical neoplasia in breast cancer patients: a population-based study.Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies Estrogen and ERalpha: culprits in cervical cancer?Rapamycin inhibits anal carcinogenesis in two preclinical animal models.Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein Short-time QiBaoMeiRan Formula Treatment Exerts Estrogenic Activities without Side Effects on Reproductive Tissues in Immature Mice Requirement for stromal estrogen receptor alpha in cervical neoplasia Human papillomaviruses as therapeutic targets in human cancer.The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter Progesterone signaling inhibits cervical carcinogenesis in mice Recurrence of cervical cancer in mice after selective estrogen receptor modulator therapy Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model.Model systems to study the life cycle of human papillomaviruses and HPV-associated cancers.Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.LKB1 as a Tumor Suppressor in Uterine Cancer: Mouse Models and Translational Studies.Human Papillomavirus and the Stroma: Bidirectional Crosstalk during the Virus Life Cycle and Carcinogenesis.Expression of Ezrin and Estrogen Receptors During Cervical Carcinogenesis.Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study.Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.17β-estradiol and progesterone effect on human papillomavirus 16 positive cells grown as spheroid co-cultures.Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?Estrogen modulation properties of mangiferin and quercetin and the mangiferin metabolite norathyriol.

P2860

Q30491596-A72C9ACE-2331-48E6-AFA5-31AF590FA1A2 Q33579159-96A7FE87-659E-4B1B-B3B8-BC44872D976F Q33710124-0C7100C1-01EA-403E-9D31-4E5056790176 Q33773092-09730244-FEDF-4AB0-92D2-25A34D1D87AE Q34037344-C6C2D453-4FE9-4143-A3C7-68B4FF703DE3 Q34679829-11679C2B-8BE6-49E3-9F51-D101FEF46502 Q34916951-875A7B1E-A178-4932-ACB6-2A2DC79D782B Q35796047-91CC038A-1378-475D-B769-DE666C128B7C Q36170110-EDDFDA33-0726-433E-B0C8-CE3BF114C15F Q36353581-F63627BD-CDB6-49EC-BC8C-BE68B88CA234 Q36522072-1F5552FD-B753-49E3-86F1-1E08A93A016D Q36910331-C9353CFB-D21F-4712-AC72-5C0B58D9C1D5 Q36973683-8171588A-5857-4685-A52F-D2249F595B7B Q37275914-3F72124D-BD20-44AE-922C-532341152391 Q37530779-1BD9B5D6-F377-4305-ADBE-E748BC9755B7 Q37537557-F1EB352A-4FD6-430D-9FF0-DB35BAF782A3 Q37709290-CCDAB3BE-CAE2-4211-9A45-62624BF2236C Q38449589-C011760A-D502-46B1-9B10-D672E901A450 Q38870528-4C5E0BEF-7D83-4BD7-AAF3-8E8A220325DF Q39026772-798A918C-BEC0-4094-B03E-CCDBA8355268 Q40089345-319A96B7-6171-4574-A838-D016AEA07D42 Q40521768-52209A43-C5FB-4555-9B09-BB4CC7CE6FF5 Q41110474-4CF5B3A2-7265-47B5-BE6B-261D9A2E23E3 Q47407749-D82CC65B-667D-4DA0-93EB-55F488233CA0 Q48234869-1EC951DA-261B-49BB-BA85-7A0E2949673D Q50995151-36498C77-6F6B-4051-AC9E-46249ACCC9A4 Q54118759-90236317-C13D-439D-9480-CFCEF5667F06

P2860

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

http://www.wikidata.org/entity/Q37428887

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

@en

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

@nl

type

label

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

@en

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

@nl

prefLabel

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

@en

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

@nl

P1433

Q37428887-C370BD7A-5907-4557-86CA-74293E1665BB

P1476

Q37428887-9F719DBC-9F62-431E-BE11-2576FADE313D

P2093

Q37428887-74A29503-9B17-42C1-8A29-092F64885527

Q37428887-A054C1F3-C39D-4FBE-9312-537DD47DCEFA

P2860

Q37428887-03086317-9048-4378-B070-A69E906C7AFD

Q37428887-0904D4D7-28D5-45C7-8BF9-F18234DB449F

Q37428887-1DF3AC61-4157-4606-9D69-63A67501F412

Q37428887-307C71FE-4E13-4604-AC0F-744260C8C1AF

Q37428887-3383C602-E155-478D-90BC-3E775D8FD6E4

Q37428887-474EBEA6-9A36-4974-AF17-41F226EC4367

Q37428887-5206BCF2-0679-49B4-8FEA-AD1211CF0B01

Q37428887-674EE8D5-C543-4B48-BBCE-0A344F86A780

Q37428887-677F45CF-1C80-432F-9104-F7CD6548BB38

Q37428887-68C912C9-6497-4F3B-B404-8010A73226BF

P304

Q37428887-CCC56885-B081-4CAC-9EBE-878A77751000

P31

Q37428887-4F2C66C7-57DE-4693-ACBC-42D5511F96C1

P356

Q37428887-088E98CF-BDDE-4590-B3B2-FC8486084F92

P407

Q37428887-BCA4BC8C-0CCD-4DCF-BD39-FF4E4AB35107

P433

Q37428887-4F85D061-8D61-4C64-AD48-CD8DE0EFF0E8

P478

Q37428887-EAAAF9BE-B564-4E83-901B-D56CBFCC9EB1

P577

Q37428887-A09BB711-BB62-4080-BB8F-A1F59CDBBD69

P5875

Q37428887-E08E1253-B5D1-4604-89DB-DC4EE2BDE673

P698

Q37428887-15A43F50-8AEF-42FB-BD80-7110432D324E

P932

Q37428887-FEE67095-EEB5-4D60-8173-8ED7C0C1A750

P356

PNAS.0911436106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

@en

P2093

Paul F Lambert

http://www.w3.org/2001/XMLSchema#string

Sang-Hyuk Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular targets and anticancer potential of indole-3-carbinol and its derivatives

Estrogen Receptors as Therapeutic Targets in Breast Cancer

Papillomaviruses and cancer: from basic studies to clinical application

The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.

The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.

Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.

Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.

Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells

Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells

How will HPV vaccines affect cervical cancer?

P304

19467-19472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0911436106

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38078166

http://www.w3.org/2001/XMLSchema#string

P698

19901334

http://www.w3.org/2001/XMLSchema#string

P932

2780740

http://www.w3.org/2001/XMLSchema#string